[0001] The subject-matter of the invention is a new method of manufacturing of bioactive
technical fibres having a widespread application both in everyday living and in medicine
as a raw-material for manufacturing of bioactive textile materials.
[0002] Following more and more intensive development of civilization and isolation of man
from microorganism potentially harmful to health or dangerous, problem of maintaining
sterility or at least microbiological stability has been still a critical issue in
many spheres of human life.
[0003] Before development of such field of science as microbiology, any bacteria or viruses
causing losses in crops, breeding or resulting in complications during treatment of
diseases, were not known all over the world. History reported plagues and crop failures
resulting from such conditions, during which recovery meant rather subordination to
natural process of elimination and natural selection of the strongest individuals.
A breakthrough in overcoming such negative aspects of human lives were discoveries
of modern medicines, for example antibiotics and various kinds of vaccinations both
for human organisms and for animals and plants. Nevertheless, despite wide access
to various chemical substances used to combat pathogenic microorganisms, both personal
and material losses resulting from non-observance of sanitary regimes are still very
common.
[0004] Potentially exposed to occurrence of biological danger are such places as medical
facilities and outreach with postoperative care. In the above, infections resulting
from non-observance of hygienic and sanitary regimes within surgical wound, occur
most frequently.
[0005] Commonly known are means used in order to combat pockets of infection as well as
pathogenic microbes. These can be disinfection and sterilizing preparations for contact
surfaces used to wash and clean places where patients stay. Their action is, however,
limited to removal of bacterial endospores and strains until the moment they are again
introduced on the washed surface, for example by its touching with carelessly sterilized
surgical instrument. Then, it is highly probable that contact with dirty surfaces
during operation will cause infection (so-called intra-hospital infection).
[0006] In the case of outreach with postoperative care, the problem of sterility or bacteriostatics
is considerably more serious. At home circumstances there are numerous objects, which
are impossible to be disinfected. Thats why it is necessary to effectively protect
the wound or environment where the patient stays, against intensified spread of microbes
already present in this environment.
[0007] Also serious danger to human health results from all kinds of air-condition and ventilation
systems provided with various types of filters, component of which are textile materials.
Microbes are developing on the filter medium and, when distributed through the system,
they cause danger both to people and animals health.
[0008] Solutions of such problems are textile materials preventing development of bacteria
known, for example, from the Soviet patent description
469720. In the process of manufacturing, textiles are enriched with sulfo groups, and then
□padded with solution of gentamicin. Production process and auxiliary activities nevertheless
guarantee a low content of biocides in the fabric structure.
[0009] In the similar way, bioactive substances are being introduced into textile material,
description of which is included into the Polish patent description
179483. Textile material is vaccinated with carboxylic acid groups and, after that and similarly
to the Soviet patent, mixtures of antibiotics with basic properties are introduced.
[0010] Another example of manufacturing of fibres with antibacterial properties is the Polish
patent description
174680. Synthetic fibres forming medical fabric are pre- bulged, and then put into a bath
in water solution of biocide and, as a result of this, it obtains its specific properties.
[0011] On the other hand, the
US patent 419656 discloses the method of fixation of active substance on nylon fabric with a stream
of hot steam and bath in water solution of oil and bioactive substance.
[0012] Nowadays also less complicated methods of bioactive fibres manufacturing are used,
consisting in mixing of molecules of active substance with fibre-forming substance,
for example polyester, thanks to what during the regular production process fibres
obtain bacteriostatic properties. It should be however noticed that as a result of
being submerged in polyester, the major part of antibiotic molecules cannot have any
contact with a zone of microbes presence, as a result of which a considerable part
of active substance is being lost for ever already at the stage of polyester adding.
[0013] Another example of fabric with antiseptic properties are fabrics of TREVIRA type
available on the market, characterized by very good bacteriostatic properties. One
of these fabrics was described in the patent
MX3009085. In the course of production textile material is padded with phosphorus compounds,
and as a result it obtains antibacterial and antifungal properties with the simultaneous
securing of permeability of dressing or clothes made of it. But in situations, when
access of air is not required, it is indispensable to apply other substances to isolate
the protected object or place from any source of potential infection.
[0014] To this end, commonly used are plastics such as, for example, food wrapping foil.
Additionally, as professional scientific magazines such as e.g Journal of Agricultural
and Chemistry announce, foils with properties similar to standard medical fabrics
are now available on the market. Such properties are possessed by foil produced by
the US Agricultural Department and the University in Ueida (Spain) and using as a
basis natural apple paste and cinnamon oil. The latter substance is responsible for
antibacterial properties, and usage of natural fruit prevents poisoning in case of
eating food together with apple foil.
[0015] In case of dressings, foils described in the patent description
WO01/51548 (Polish patent application
p-355941) are used. Depending on workmanship, foil according to the patent description, possesses
or does not possess pores passing steam through, whereas dimensions of these pores
form barrier for bacteria present in any hospital environment. Application of the
foil is connected with the fact, that it is resistant to action of the majority of
bacteria, but it itself does not possess bactericidal or bacteriostatic properties.
Pseudo-bacteriostatics results from dimensions of openings (pores) made in it, without
which this will be not steam-permeable.
[0016] Application of materials preventing passing of microbes into the area protected by
the above, and especially coated with bactericidal substances or bacteriostatic foil
or fabrics, gives apparent effects such as decreased number of infections and decreased
number of potential pockets of infection, but materials having been manufactured until
now make it necessary to observe certain regimes both during production and usage
of the above.
[0017] In the course of production such requirements refer to the method of coating fabric
or foil with bioactive components, as well as to final finishing which needs application
of additional substances or equipment for disinfection to eliminate auxiliary agents
used in production. On the other hand, in the course of using such a product, one
should be aware of the fact that not the whole bioactive substance has a contact with
an area of potential infection and, what results from this fact □this area is not
protected in a way it should be.
[0018] Solution of such problems consists in the application of technical fibres coated
with bioactive substance and made basing on the method according to the invention,
which not only ensures improvement of bacteriostatic and/or bactericidal properties
of the final product e.g. of the fabric, but also enables lowering of manufacturing
costs, improving considerably productivity of technical material produced with the
application of this method.
[0019] The method according to the invention consists in coating and fixation of active
substance, preferably having antiseptic and antibacterial properties, on the surface
of material incorporating properties of foil and then, in producing fibres from it.
[0020] In order to obtain uniform and permanent bonding of active substance with material,
it is being moved by means of step conveyor above and/or under the field where surface
of material is charged electrostatically. Such charging is completed by means of any
known technique, preferably by corona discharge or by means of rubbing with a kind
of brushes, which place static charges on the surface of material. Electrostatic charging
is carried out in the situation when bioactive substance indicates susceptibility
to action of electrostatic field. Preferably, the electrode charging the surface of
material is string electrode.
[0021] Next, the treated material is being transferred through the area, where it is coated,
preferably by means of dusting at least one-sided, preferably double-sided, with biologically
active substance. Preferably, properties of spread substance enable combating and
preventing development of bacteria and viruses. Preferably, such a substance has a
form of nano- or micro- powder, particles of which have dimensions falling within
the range from 10
-6 up to 10
-9 m.
[0022] Directly after dusting of material surface with active substance, the material passes
through a zone characterized by higher temperature. Preferably, a suitable temperature
is obtained with the application of infrared radiator. Preferably, height of temperature
corresponds to temperature of material melting, preferably such temperature is not
higher than temperature of the treated material destruction. As a result of heat action
and preferably thanks to application of auxiliary calenders, preferably roller calenders,
the active substance is pressed to material surface, preferably being a foil. Preferably,
when pressure is associated with cooling of the surface or when cooling follows directly
after the material, preferably foil, has left the area of roller calender.
[0023] After passing through the calendering □ pressing zone material, preferably foil,
is directed towards the known equipment for fibrillation and capillarization, or both
fibrillation and capillarization simultaneously. Preferably, the structure of calendering
zone ensures fulfillment of these functions, too. Preferably, when during passing
through the zone of material fibrillation, preferably foil with active substance spread
over at least one surface, is treated with the application of at least one needle
fibrillator. On leaving a zone of fibrillation material, preferably foil, is being
torn into thin fibres with a breaker. The final products received as a result of the
above are technical bioactive fibres. These fibres may constitute a raw-material used
over the successive production stage □formation of non-woven material. It is completed
with the application of any known technique, and bacteriostatic properties of raw-material
such as fibres, eliminate additional operations of disinfection or giving bactericidal
and bacteriostatic properties.
[0024] From the final product different products can be produced, starting from technical
products such as e.g. covers used to protect operational zones for medical staff clothing
or filter materials for air filters installed in operating theaters. All of them preserve
their properties as time goes by, and permanent joining of active substance only with
fibre surface ensures contact of 100% of this substance with a potential pocket of
inflation.
[0025] The subject-matter according to the invention has been schematically presented in
the figure, where Fig. 1 shows the course of the entire process of bioactive fibres
manufacturing.
[0026] The main component of the final product is material coated with biologically active
substance and fibre made of the above. In order to obtain uniform and permanent bonding
of active substance with treated material, pressed with under-roll rollers, the roll
1 of material 2 in the zone I, is moved by means of step conveyor 3 above and/or under
the field, where surfaces of material are charged electrostatically with the string
electrode 4 to the zone II. Such charging is completed by means of corona discharge
or, according to the other example of making, by means of rubbing with a kind of brushes,
placing static charges on the surface of material.
[0027] Next, the material 2 is being transferred through the area, where it is coated by
means of dusting with biologically active substance with the application of pulverizer
provided with dispenser 5. Properties of the spread substance enable combating and/or
preventing development of bacteria and viruses. Such a substance has a form of nano-
or micro- powder, particles of which have dimensions falling within the range from
10
-6 up to 10
-9 m.
[0028] Directly after dusting of material surface 2 with active substance, the material
2 passes through the zone III, where an area characterized by higher temperature is
located. A suitable temperature is obtained with the application of infrared radiator
6. Height of temperature corresponds to initial temperature of material 2 melting
and it is not higher than temperature of the treated material 2 destruction. As a
result of heat action and thanks to application of auxiliary calenders 7, being roller
calenders, the active substance is pressed to material surface 2. This pressure is
associated with cooling of the surface, which follows directly after the material
2 has left the area of roller calenders 7.
[0029] After passing through the calendering □pressing zone IV, the material 2 is directed
towards the known equipment for fibrillation 8 installed in the zone V. The equipment
for fibrillation is a needle fibrillator On leaving the zone V, material 2 is being
torn into thin fibres with a breaker 9 in the zone VI. The received fibres 10 fall
into the container 11 and are the final product in a form of technical bioactive fibres.
These fibres may constitute a raw-material used in the other textile processes, e.g.
for formation of non-woven material. This can be completed with the application of
any known technique, and bacteriostatic properties of raw-material such as fibres,
eliminate additional operations of disinfection or giving bactericidal and bacteriostatic
properties.
1. The method of manufacturing of bioactive technical fibres, characterized in that on surface of the material 2 with properties of foil, bioactive substance is spread
and fixed in the zone III of higher temperature, and next □the material 2 is calendered
in the zone IV and fibrilled in the zone V and, after that, torn into pieces in order
receive the fibres 10
2. The method according to the claim 1, characterized in that web or sheet of the material 2 is being moved by means of the step conveyor 3 above
and/or under the field II, where surface/-es of the material 2 is/are charged electrostatically.
3. The method according to the claim 2, characterized in that electrostatic charging of the material 2 is carried out by means of the electrode
4.
4. The method according to the claim 3, characterized in that the electrode 4 used to charge electrostatically surface of the material 2 is a string
electrode.
5. The method according to the claim 2 or 3 or 4, characterized in that the material 2 is being transferred through the zone II, where it is coated at least
one-sided with biologically active substance.
6. The method according to the claim 5, characterized in that properties of coating substance enable to combat or prevent development of bacteria
or viruses.
7. The method according to the claim 5 or 6, characterized in that the substance has a form of nano- or micro-powder, particles of which have dimensions
falling within the range from 10-6 up to 10-9 m.
8. The method according to the claim 7, characterized in that directly after the material 2 has been coated with active substance, the material
2 passes through the zone III characterized by the higher temperature.
9. The method according to the claim 1, characterized in that a suitable temperature is obtained with the application of infrared radiator.
10. The method according to the claim 8 or 9, characterized in that height of temperature corresponds to the initial temperature of melting for the material
2.
11. The method according to the claim 10, characterized in that bioactive substance is pressed to surface of the material 2 by means of the calenders
7 or when cooling occurs directly after the material 2 has left the area of roller
calenders 7.
12. The method according to the claim 10 or 11, characterized in that pressure of the calenders 7 is associated with simultaneous cooling of the material
2 surface.
13. The method according to the claim 10 or 11, characterized in that cooling is carried out directly after the material 2 has left the area of the roller
calenders 7.
14. The method according to the claim 12 or 13, characterized in that after passing through the calendering □pressing zone IV, the material 2 is directed
to the known equipment for fibrillation and/or capillarization 8.
15. The method according to the claim 14, characterized in that during passing through the fibrillation zone V, the material 2 with active substance
spread over at least one surface of it, is treated by means of at least one needle
fibrillator 8.
16. The method according to the claim 14 or 15, characterized in that after leaving the fibrillation zone V, the material 2 is torn to receive thin fibres
10 with the breaker 9.
17. The method according to the claim 1 or 2 or 3 or 4 or 5 or 8 or 10 or 11 or 12 or
13 or 14 or 15 or 16, characterized in that the material 2 is foil.